ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Your willingness to take risks is written in your genes
15. January 2019
New application programme open for experienced researchers
14. January 2019
Transparent mice map the brain’s washing machine
4. January 2019